Lucid Diagnostics reported first-quarter 2025 revenue of $0.8 million, representing a year-over-year decline of approximately 20%. This performance fell short of analyst expectations, highlighting the ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Lantheus Holdings, Inc. (NASDAQ:LNTH), a leading provider of diagnostic and therapeutic products with a focus on medical imaging, finds itself at a critical juncture. Trading at a P/E ratio of 13.6x ...

Quest Diagnostics (NYSE:DGX), a leading provider of diagnostic testing and information services, is charting a course for growth through strategic acquisitions and operational improvements. The ...

Laboratory Corporation of America Holdings, commonly known as Labcorp, stands as a prominent player in the clinical laboratory services industry, with a substantial market capitalization of $22.58 ...

Report Ocean recently released a new report on the global Liver Cancer Molecular Diagnostics Market. This study report is a combination of data and analysis gleaned from several sources to help ...

Quest Diagnostics Inc's robust financial performance with $9.3 billion in net revenues for 2023. Strategic acquisitions and innovative diagnostic solutions driving growth. Commitment to quality and ...

Quest Diagnostics Inc (NYSE:DGX) maintains a dominant position in the diagnostic information services industry. Recent acquisition of LifeLabs Inc. indicates strategic expansion and growth potential.